Focused Expertise in Gastrointestinal Cancers

Dr. Azriel Hirschfeld is a specialist in gastrointestinal cancers, with a subspecialty in pancreatic cancer. His innovative methods extend across Bile Duct, Colon, and Gastric cancers — offering patients new options when standard treatments fail.

While his primary expertise lies in GI cancers, he has also applied his approach successfully to Breast and Ovarian cancers, particularly in advanced or treatment-resistant cases.

request a consultation

Expanding Innovation Beyond GI

Although GI cancers remain the primary focus, Dr. Hirschfeld’s proven methodology has also been used with success in select cases of breast and ovarian cancer.

These treatments are considered particularly for patients facing resistant or late-stage disease, where other options have failed.

Ovarian Cancer

Personalized strategies for late-stageUsing his evidence-based, low-toxicity regimens, Dr. Hirschfeld has helped women with recurrent or resistant ovarian cancer respond where traditional approaches have failed or platinum-resistant ovarian cancers.

Learn More About Ovarian Cancer

Breast Cancer

For patients with aggressive or refractory breast cancer, Dr. Hirschfeld applies the same innovative, low-dose, multi-drug approach used in GI cancers. Many of these patients—previously heavily treated and told they had no options—have experienced meaningful responses and renewed hope.

Learn More About Breast Cancer

Extending Care Beyond Our Core Focus

While our primary focus is on gastrointestinal cancers, our expertise extends to a wider range of cancers as well. Dr. Hirschfeld applies the same innovative, personalized approach to conditions such as esophageal, lung, liver, and uterine cancers.

Esophageal Cancer

Our approach to esophageal cancer blends proven therapies with innovative methods, ensuring patients receive care matched to their specific needs.

Learn More About Esophageal Cancer

Standard When It Works, Innovation When It’s Needed

Learn more about us

Low-Dose Multi-Drug Combinations

By combining 4–6 chemotherapy drugs at lower doses, Dr. Hirschfeld reduces side effects while maximizing the synergy between medicines to fight cancers more effectively.

Repurposed Medicines

Well-established drugs from other medical fields are safely adapted to oncology, opening new treatment paths for patients who have already exhausted standard options.

Genomic profiling

Each tumor’s unique genetic profile is analyzed, allowing therapies to be precisely matched to the cancer’s biology for greater accuracy and impact.

Data-Driven Off-Label Use

When evidence strongly supports benefit, FDA-approved drugs are used off-label, giving patients earlier access to promising treatments beyond standard protocols.

Real Stories, Real Hope

Professional, gifted, and unlike any other

Dr. Azriel Hirschfeld is a servant to his profession--a close listener, smart as a whip, patient, kind, informed and above all a learner. Have been to a swarm of doctors on our journey and not one measures up to this doctor's professionalism and giftedness. He is a rare find.

Cristina M

Happy Patient

Professionalism and True Giftedness

BEST ONCOLOGIST in the world 🙏🏻 I am forever thankful to have found him . Dr. Hirshfeld is very patient and listens . Unlike other places I am NOT just a number to him , he cares and it shows .

Sima Homapour

Happy Patient

Frequently asked questions

For any unanswered questions, reach out to our support team via email. We'll respond as soon as possible to assist you.